Publications by authors named "David Chatenet"

Claim this Profile
S
Structure-activity relationships of contulakin-G: Design, synthesis, and characterization of Thr analogs for pain modulation.
Annik Lanoie, Sára Ferková, Édouard Caron-Duval, Juliana C C Dallagnol, Sitan Diarra, David Chatenet

Biomed Pharmacother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation With Local, Sustained Delivery of Pituitary Adenylate Cyclase Activating Polypeptide Results in Improved Functional Recovery in Stroke-Injured Mice.
Eric Ho, David Xinzheyang Li, Hong Cui, Dania Akbar, Ricky Siu, David Chatenet

Adv Healthc Mater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer.
Philippine Granger Joly de Boissel, Rita Nehmé, Marlène Fortier, Myriam Létourneau, Brigitte Guérin, David Chatenet

ACS Pharmacol Transl Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Gαq Signaling in -Deficient Cells Is Required for Their Neoplastic Behavior.
Aurélie Tréfier, Nihad Tousson-Abouelazm, Lama Yamani, Sajida Ibrahim, Kwang-Bo Joung, David Chatenet

Am J Respir Cell Mol Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer.
Rita Nehmé, Marlène Fortier, Myriam Létourneau, Camille Fuselier, Philippine Granger Joly de Boissel, David Chatenet

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT receptor.
Etienne Billard, Alexandre Torbey, Antonio Inserra, Emily Grant, Antonella Bertazzo, David Chatenet

Cell Signal· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators.
Francesco Merlino, Agnese Secondo, Emma Mitidieri, Raffaella Sorrentino, Rosa Bellavita, David Chatenet

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors.
Hassan Nassour, Darlaine Pétrin, Dominic Devost, Etienne Billard, Rory Sleno, David Chatenet

Cell Signal· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics.
Xiaozheng Wei, Sitan Diarra, Antoine Douchez, Juliana C Cunico Dallagnol, Terence E Hébert, David Chatenet

J Med Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts.
Juliana C C Dallagnol, Mikhail Volkovich, David Chatenet, Bruce G Allen, Terence E Hébert

ACS Chem Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the urocontrin A scaffold yields new urotensinergic system allosteric modulator and competitive antagonists.
Etienne Billard, Terence E Hébert, David Chatenet

Biochem Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel-Nanoparticle Drug Delivery System.
Eric Ho, Yaoqi Deng, Dania Akbar, Kevin Da, Myriam Létourneau, David Chatenet

ACS Appl Mater Interfaces· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental Galectins in Cancer: Why We Should Pay More Attention.
Camille Fuselier, Alyssa Dumoulin, Alex Paré, Rita Nehmé, Samy Ajarrag, David Chatenet

Cells· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complicated lives of GPCRs in cardiac fibroblasts.
Grace R Mazarura, Juliana C C Dallagnol, David Chatenet, Bruce G Allen, Terence E Hébert

Am J Physiol Cell Physiol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Biomolecular Interactions Using Slow Mixing Mode (SLOMO) Nanoflow ESI-MS.
Duong T Bui, Zhixiong Li, Pavel I Kitov, Ling Han, Elena N Kitova, David Chatenet

ACS Cent Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7.
N T Hang Pham, Myriam Létourneau, Marlène Fortier, Gabriel Bégin, M Sameer Al-Abdul-Wahid, David Chatenet

J Biol Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands.
Hassan Nassour, Tuan Anh Hoang, Ryan D Martin, Juliana C C Dallagnol, Étienne Billard, David Chatenet

J Biol Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of a Soluble -Tetraarylporphyrin to Human Galectin-7 Induces Oligomerization and Modulates Its Pro-Apoptotic Activity.
Yossef López de Los Santos, David N Bernard, Philippe Egesborg, Myriam Létourneau, Clara Lafortune, David Chatenet

Biochemistry· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A Action.
Etienne Billard, David Chatenet

ACS Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spt5 Phosphorylation and the Rtf1 Plus3 Domain Promote Rtf1 Function through Distinct Mechanisms.
Jennifer J Chen, Jean Mbogning, Mark A Hancock, Dorsa Majdpour, Manan Madhok, David Chatenet

Mol Cell Biol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor.
Mathilde Poujol de Molliens, Priyanka Jamadagni, Myriam Létourneau, Dominic Devost, Terence E Hébert, David Chatenet

Biochim Biophys Acta Gen Subj· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.
Chenyi Liao, Mathilde P de Molliens, Severin T Schneebeli, Matthias Brewer, Gaojie Song, David Chatenet

Curr Top Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Targeting the Urotensinergic System: Overview and Challenges.
Hassan Nassour, Mustapha Iddir, David Chatenet

Trends Pharmacol Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide.
Somia Debbabi, Marie-Christine Groleau, Myriam Létourneau, Chitra Narayanan, Laura-Lee Gosselin, David Chatenet

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.
Francesco Merlino, Étienne Billard, Ali M Yousif, Salvatore Di Maro, Diego Brancaccio, David Chatenet

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis